Literature DB >> 15801948

Different accumulation of temocapril and enalapril during repeated dosing in elderly patients.

Masashi Arakawa, Masami Ohmori, Ken-ichi Harada, Nobutaka Araki, Tetsuo Saitoh, Akio Fujimura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15801948      PMCID: PMC1884808          DOI: 10.1111/j.1365-2125.2005.02346.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Determination in plasma of angiotensin-converting enzyme inhibitor by inhibitor-binding assay.

Authors:  H Shioya; M Shimojo; Y Kawahara
Journal:  J Chromatogr       Date:  1991-08-23

2.  Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).

Authors:  H Ishizuka; K Konno; H Naganuma; K Sasahara; Y Kawahara; K Niinuma; H Suzuki; Y Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  1997-03       Impact factor: 4.030

Review 3.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

4.  Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide.

Authors:  H Ishizuka; K Konno; H Naganuma; K Nishimura; H Kouzuki; H Suzuki; B Stieger; P J Meier; Y Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  1998-10       Impact factor: 4.030

5.  Study on pharmacokinetics of a new biliary excreted oral angiotensin converting enzyme inhibitor, temocapril (CS-622) in humans.

Authors:  H Suzuki; T Kawaratani; H Shioya; Y Uji; T Saruta
Journal:  Biopharm Drug Dispos       Date:  1993-01       Impact factor: 1.627

6.  Pharmacokinetics of temocapril and enalapril in patients with various degrees of renal insufficiency.

Authors:  H Oguchi; M Miyasaka; T Koiwai; S Tokunaga; K Hora; K Sato; T Yoshie; H Shioya; S Furuta
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.